In patients with obesity undergoing pancreatic clamp, high-dose glucagon infusion suppressed hepatic VLDL–triglyceride secretion, with a corresponding reduction in plasma VLDL–triglyceride levels. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.